Literature DB >> 8558651

Voiding dysfunction in human immunodeficiency virus infections.

C J Kane1, D M Bolton, J A Connolly, E A Tanagho.   

Abstract

PURPOSE: We prospectively evaluated the current spectrum of urodynamic pathology in patients infected with human immunodeficiency virus (HIV) who presented with voiding dysfunction.
MATERIALS AND METHODS: We obtained a directed genitourinary and neurological history, and performed a physical examination and urodynamic testing in 18 patients. A 4-channel membrane urethral catheter was used to record intravesical and intraurethral pressures simultaneously.
RESULTS: Detrusor hyperreflexia was present in 28% of our patients and detrusor-sphincter dyssynergia in 28%. Detrusor areflexia, previously described as the most frequent abnormality, was uncommon in our series (6% of patients).
CONCLUSIONS: This changing proportion of urodynamic diagnoses may reflect a changing pattern of neurological manifestations of HIV infection due to more aggressive management. Urodynamic evaluation remains critical for precise diagnosis and treatment in patients with HIV who present with urinary symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8558651

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  HIV status is an independent risk factor for reporting lower urinary tract symptoms.

Authors:  Benjamin N Breyer; Stephen K Van den Eeden; Michael A Horberg; Michael L Eisenberg; Donna Y Deng; James F Smith; Alan W Shindel
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

2.  Long COVID and COVID-19-associated cystitis (CAC).

Authors:  Laura E Lamb; Ryan Timar; Melissa Wills; Sorabh Dhar; Steve M Lucas; Dragana Komnenov; Michael B Chancellor; Nivedita Dhar
Journal:  Int Urol Nephrol       Date:  2021-11-17       Impact factor: 2.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.